text
"['\nIX. 계열회사 등에 관한 사항\n타법인출자 현황\n(기준일 :\xa0\n2017년 12월 31일\n)\n(단위 : 백만원, 주, %)\n법인명\n최초취득일자\n출자목적\n최초취득금액\n기초잔액\n증가(감소)\n기말잔액\n최근사업연도재무현황\n수량\n지분율\n장부가액\n취득(처분)\n평가손익\n수량\n지분율\n장부가액\n총자산\n당기순손익\n수량\n금액\n천진신풍제약유한공사\n1995.03.31\n-\n3,299\n-\n45.0\n3,299\n-\n-\n-\n-\n45.0\n3,299\n15,784\n-1,698\n신풍대우베트남파마(유)\n1996.10.14\n-\n7,402\n-\n96.6\n10,130\n-\n-\n-\n-\n96.6\n10,130\n12,312\n447\nGeneral Medicine Company Ltd.\n1988.02.28\n-\n742\n-\n33.3\n742\n-\n-\n-\n-\n33.3\n742\n38,642\n12,479\n필리핀신풍파마\n2002.08.26\n-\n95\n-\n80.0\n95\n-\n-\n-\n-\n80.0\n95\n1,529\n158\nSP International\n2013.07.15\n-\n100\n-\n100.0\n2,930\n-\n-\n-1,868\n-\n100.0\n1,062\n2,886\n0\n미얀마신풍파마\n2014.07.17\n-\n51\n-\n100.0\n51\n-\n-\n-\n-\n100.0\n51\n370\n-301\n신풍USA\n2017.11.23\n-\n1,134\n-\n-\n-\n100,000\n1,134\n-\n100,000\n100.0\n1,134\n1,134\n0\n씨바이오맥스\n2017.12.14\n-\n630\n-\n-\n-\n67,000\n630\n-\n67,000\n25.1\n630\n770\n-164\n합 계\n-\n-\n17,247\n-\n1,764\n-1,868\n-\n-\n17,143\n73,427\n10,921\n']"
